The Investigators Brochure

What is The Investigators Brochure?

The Investigators Brochure is a comprehensive document that provides detailed information about an investigational drug or medical device. It is typically created by the sponsor of the study and serves as a valuable resource for investigators, regulatory authorities, and ethics committees.

What are the types of The Investigators Brochure?

There are two main types of Investigators Brochure: 1. The Initial Investigators Brochure: This document is developed during the early stages of the study and provides key information about the investigational drug or device, including its chemistry, pharmacology, and safety data. 2. The Updated Investigators Brochure: As the study progresses and more data becomes available, the Initial Investigators Brochure is updated with additional information and findings. It ensures that the investigators and other stakeholders have access to the most up-to-date information.

Initial Investigators Brochure
Updated Investigators Brochure

How to complete The Investigators Brochure

Completing The Investigators Brochure requires careful attention to detail and adherence to regulatory guidelines. Here are the steps to follow: 1. Collect all relevant information: Gather data on the investigational drug or device, including its composition, manufacturing process, and preclinical and clinical studies. 2. Organize the information: Arrange the collected data in a logical and accessible manner, ensuring that all sections required by regulatory authorities are included. 3. Review and update: Regularly review and update the Investigators Brochure as new data becomes available or changes occur. 4. Seek input: Consult with experts, investigators, and regulatory authorities to ensure the accuracy and completeness of the document. 5. Submit for approval: Submit the completed Investigators Brochure to the appropriate regulatory authorities for review and approval before initiating the study.

01
Collect all relevant information
02
Organize the information
03
Review and update
04
Seek input
05
Submit for approval

pdfFiller empowers users to create, edit, and share documents online. Offering unlimited fillable templates and powerful editing tools, pdfFiller is the only PDF editor users need to get their documents done.

Video Tutorial How to Fill Out The Investigators Brochure

Thousands of positive reviews can’t be wrong

Read more or give pdfFiller a try to experience the benefits for yourself
5.0
I received excellent customer service.
I received excellent customer service… I received excellent customer service from pdf filler...it was both prompt and courteous!!
sharon b
5.0
EASY GOOD EASY TO USE I FOUND ALL THE DOCUMENTS I WANTED EVEN HAD INSTRUCTION AS...
EASY GOOD EASY TO USE I FOUND ALL THE DOCUMENTS I WANTED EVEN HAD INSTRUCTION AS TO HOW TO FILL THEM OUT
michael miller
4.0
Learning as I go Learning as I go.
Learning as I go Learning as I go. Some difficulty on how to enter long names - finding ways to do that.
Nancy Staton

Questions & answers

Investigator's Brochure (IB) is a document which contains all the available clinical and non-clinical data on the Investigational Product(s) that are known and relevant to the study of the product.
Introduction: A thorough discussion of the known effects of the investigational product(s) in humans should be provided, including information on pharmacokinetics, metabolism, pharmacodynamics, dose response, safety, efficacy, and other pharmacological activities.
7.2 General Considerations The IB should include: This should provide the sponsor's name, the identity of each investigational product (i.e., research number, chemical or approved generic name, and trade name(s) where legally permissible and desired by the sponsor), and the release date.
The purpose of the IB is to compile data relevant to studies of the investigational product in human subjects gathered during preclinical and other trials. An IB is intended to provide the investigator with insights necessary for management of study conduct and study subjects throughout a clinical trial.
Information in the IB should be presented in a concise, simple, objective, balanced, and non-promotional form that enables a clinician, or potential investigator, to understand it and make his/her own unbiased risk-benefit assessment of the appropriateness of the proposed trial.
As for most documents, a concise and focused presentation style will have the best chances of communicating the necessary messages to the intended audience. In practice, an IB should not need to exceed ∼100 pages, and a shorter document can also be sufficient.